JUN 10, 2015 07:30 AM PDT

The Future of Laboratory Reimbursements

Speakers
  • Executive Vice President Emeritus, ASCLS
    Biography
      Elissa Passiment is the Executive Vice President of the American Society for Clinical Laboratory Science (ASCLS). She is a clinical laboratory scientist with over twenty years experience in clinical laboratories as staff, educator and manager and another twenty years in health care consulting, association management and health policy. Ms. Passiment uses her science background and experience to analyze policies and systems as they relate to the future of health care, its changing emphasis, reimbursement, patient safety, quality delivery and business potential. She has served on the congressionally mandated Negotiated Rulemaking Committee convened to standardize and simplify reimbursement for laboratory services under Medicare Part B; presented testimony to Institute of Medicine studies, and represents ASCLS at meetings with the FDA, CMS, and CDC. She is also on the Editorial Board of Lab Tests Online. She was a member of the Clinical Laboratory Improvement Advisory Committee (CLIAC) from 2007-2011 and served as Chair for 2009-11. She is the recipient of numerous awards, including the Laboratory Public Service National Leadership Award.

    Abstract:
    CMS continues to make changes to how all healthcare providers are reimbursed in attempts to control the cost of the services provided to Medicare beneficiaries. This has led to value-based reimbursement, quality measures and "packaging" of service payments. CMS is also charged with recalculating the clinical laboratory fee schedule, which may or may not be important depending on how we are paid for our services. We will look at these trends and discuss their impact on how we take care of our patients.

    Show Resources
    You May Also Like
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUN 18, 2019 04:00 PM CEST
    C.E. CREDITS
    JUN 18, 2019 04:00 PM CEST
    DATE: June 18, 2019TIME: 7:00am PDT, 10:00 EDT, 4:00pm CET PSCs represent an important tool in a wide range of applications, including basic research, disease modeling, drug...
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    Loading Comments...
    Show Resources